Logo image of ID

PARTS ID INC (ID) Stock Fundamental Analysis

NYSEARCA:ID - NYSE Arca - US7021411027 - Common Stock - Currency: USD

0.0489  -0.04 (-43.34%)

Fundamental Rating

1

ID gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. Both the profitability and financial health of ID have multiple concerns. ID has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ID had negative earnings in the past year.
ID had a negative operating cash flow in the past year.
In multiple years ID reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ID reported negative operating cash flow in multiple years.
ID Yearly Net Income VS EBIT VS OCF VS FCFID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

1.2 Ratios

The Return On Assets of ID (-125.53%) is worse than 96.90% of its industry peers.
Industry RankSector Rank
ROA -125.53%
ROE N/A
ROIC N/A
ROA(3y)-37.31%
ROA(5y)-22.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ID Yearly ROA, ROE, ROICID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 50 -50 100 150

1.3 Margins

Looking at the Gross Margin, with a value of 18.47%, ID is doing worse than 82.17% of the companies in the same industry.
ID does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ID Yearly Profit, Operating, Gross MarginsID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 5 -5 10 15 20

More info and screens

0

2. Health

2.1 Basic Checks

ID does not have a ROIC to compare to the WACC, probably because it is not profitable.
ID has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ID has a worse debt to assets ratio.
ID Yearly Shares OutstandingID Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
ID Yearly Total Debt VS Total AssetsID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

ID has an Altman-Z score of -0.77. This is a bad value and indicates that ID is not financially healthy and even has some risk of bankruptcy.
ID's Altman-Z score of -0.77 is on the low side compared to the rest of the industry. ID is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACC8.54%
ID Yearly LT Debt VS Equity VS FCFID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M

2.3 Liquidity

A Current Ratio of 0.12 indicates that ID may have some problems paying its short term obligations.
ID's Current ratio of 0.12 is on the low side compared to the rest of the industry. ID is outperformed by 99.22% of its industry peers.
ID has a Quick Ratio of 0.12. This is a bad value and indicates that ID is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.10, ID is doing worse than 95.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.1
ID Yearly Current Assets VS Current LiabilitesID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

ID shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -120.83%.
Looking at the last year, ID shows a very negative growth in Revenue. The Revenue has decreased by -57.44% in the last year.
EPS 1Y (TTM)-120.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)-57.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.56%

3.2 Future

Based on estimates for the next years, ID will show a very strong growth in Earnings Per Share. The EPS will grow by 28.87% on average per year.
ID is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.05% yearly.
EPS Next Y74.74%
EPS Next 2Y46.15%
EPS Next 3Y34.04%
EPS Next 5Y28.87%
Revenue Next Year3.26%
Revenue Next 2Y4.62%
Revenue Next 3Y5.41%
Revenue Next 5Y6.05%

3.3 Evolution

ID Yearly Revenue VS EstimatesID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ID Yearly EPS VS EstimatesID Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 0.68, which indicates a rather cheap valuation of ID.
Based on the Price/Forward Earnings ratio, ID is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.21. ID is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.68
ID Price Earnings VS Forward Price EarningsID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ID Per share dataID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ID's earnings are expected to grow with 34.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.15%
EPS Next 3Y34.04%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ID!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARTS ID INC

NYSEARCA:ID (12/26/2023, 8:04:00 PM)

0.0489

-0.04 (-43.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-14 2023-11-14
Earnings (Next)04-15 2024-04-15/amc
Inst Owners0.04%
Inst Owner Change0%
Ins Owners10.63%
Ins Owner Change0%
Market Cap1.70M
Analysts40
Price Target1.02 (1985.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-83.65%
Min Revenue beat(2)-85.72%
Max Revenue beat(2)-81.58%
Revenue beat(4)0
Avg Revenue beat(4)-50.48%
Min Revenue beat(4)-85.72%
Max Revenue beat(4)-9.42%
Revenue beat(8)1
Avg Revenue beat(8)-29.43%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.68
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)0.07
Fwd EY147.44%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS4.99
BVpS-1.02
TBVpS-1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -125.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.47%
FCFM N/A
ROA(3y)-37.31%
ROA(5y)-22.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover9.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.85%
Cap/Sales 2.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.1
Altman-Z -0.77
F-Score2
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)93.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-120.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y74.74%
EPS Next 2Y46.15%
EPS Next 3Y34.04%
EPS Next 5Y28.87%
Revenue 1Y (TTM)-57.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.56%
Revenue Next Year3.26%
Revenue Next 2Y4.62%
Revenue Next 3Y5.41%
Revenue Next 5Y6.05%
EBIT growth 1Y-29.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.34%
EBIT Next 3Y52.05%
EBIT Next 5Y44.28%
FCF growth 1Y-172.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-135.44%
OCF growth 3YN/A
OCF growth 5YN/A